1
Matic, Maja, Nijenhuis, Marga, Soree, Bianca, de Boer-Veger, Nienke J., Buunk, Anne-Marie, Houwink, Elisa J. F., Mulder, Hans, Rongen, Gerard A. P. J. M., van der Weide, Jan, Wilffert, Bob, Swen, Jesse J., Guchelaar, Henk-Jan, Deneer, Vera H. M., van Schaik, Ron H. N.
Veröffentlicht in: Matic , M , Nijenhuis , M , Soree , B , de Boer-Veger , N J , Buunk , A-M , Houwink , E J F , Mulder , H , Rongen , G A P J M , van der Weide , J , Wilffert , B , Swen , J J , Guchelaar , H-J , Deneer , V H M & van Schaik , R H N 2022 , ' Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) ' , European Journal of Human Genetics , pp. 1105–1113 . https://doi.org/10.1038/s41431-021-00920-y;
2022
Veröffentlicht in: Matic , M , Nijenhuis , M , Soree , B , de Boer-Veger , N J , Buunk , A-M , Houwink , E J F , Mulder , H , Rongen , G A P J M , van der Weide , J , Wilffert , B , Swen , J J , Guchelaar , H-J , Deneer , V H M & van Schaik , R H N 2022 , ' Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) ' , European Journal of Human Genetics , pp. 1105–1113 . https://doi.org/10.1038/s41431-021-00920-y;
2022
2
Brouwer, Jurriaan M. J. L., Nijenhuis, Marga, Soree, Bianca, Guchelaar, Henk-Jan, Swen, Jesse J., van Schaik, Ron H. N., van der Weide, Jan, Rongen, Gerard A. P. J. M., Buunk, Anne-Marie, De Boer-Veger, Nienke J., Houwink, Elisa J. F., van Westrhenen, Roos, Wilffert, Bob, Deneer, Vera H. M., Mulder, Hans
Veröffentlicht in: Brouwer , J M J L , Nijenhuis , M , Soree , B , Guchelaar , H-J , Swen , J J , van Schaik , R H N , van der Weide , J , Rongen , G A P J M , Buunk , A-M , De Boer-Veger , N J , Houwink , E J F , van Westrhenen , R , Wilffert , B , Deneer , V H M & Mulder , H 2022 , ' Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs ' , European Journal of Human Genetics , vol. 30 , pp. 1114–1120 . https://doi.org/10.1038/s41431-021-01004-7;
2022
Veröffentlicht in: Brouwer , J M J L , Nijenhuis , M , Soree , B , Guchelaar , H-J , Swen , J J , van Schaik , R H N , van der Weide , J , Rongen , G A P J M , Buunk , A-M , De Boer-Veger , N J , Houwink , E J F , van Westrhenen , R , Wilffert , B , Deneer , V H M & Mulder , H 2022 , ' Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs ' , European Journal of Human Genetics , vol. 30 , pp. 1114–1120 . https://doi.org/10.1038/s41431-021-01004-7;
2022
3